First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Sources of information and study methodology
Close this folder3. Dissemination and uptake of the Guidelines
View the documentThe development stage: September 1994 - May 1996
View the documentThe launch: May 1996
View the documentAfter May 1996: dissemination of the Guidelines
View the documentOther publications about drug donations
View the documentConferences at which the Guidelines were discussed
View the documentInternational organizations subscribing to the Guidelines
View the documentCountries and national organizations that have adapted or adopted the Guidelines
View the documentOther country studies on drug donations
Open this folder and view contents4. Basic characteristics of drug donations
Open this folder and view contents5. Practical benefits as a result of the Guidelines
View the document6. Drug donations which were hampered, delayed or cancelled
Open this folder and view contents7. Experiences and opinions regarding the 12-month shelf-life requirement
Open this folder and view contents8. Other suggestions to improve the Guidelines
Open this folder and view contents9. How could donation practice be further improved?
View the document10. Summary of recommendations
View the document11. Postscript
View the documentReferences
 

After May 1996: dissemination of the Guidelines

The English version of the Guidelines was issued in May 1996. Hundreds of copies were disseminated through the WHO mailing lists. Each of the organizations in the interagency group received about 500 copies for dissemination through their regional and field offices. OXFAM received 1,000 copies for distribution to nongovernmental organizations, especially those dealing with Romania. The Guidelines were also made available through the DAP web site. In total, about 8,000 copies were printed and distributed in English in the first year. In March 1997 WHO published an article on the Guidelines in the British Medical Journal. In addition, the Guidelines were included in a chapter on drug donations in the second edition of the standard textbook, Managing drug supply,3 which appeared in April 1997.

Translations into other languages followed. In August 1996 the French edition was issued and in September the Spanish translation. In total, over 6,000 copies were printed and distributed in these two languages. In December 1996 the Guidelines were reproduced in their entirety in the Essential Drugs Monitor (No. 21) in English, later followed by editions in French, Spanish and Russian; a total of about 35,000 copies were printed. In the subsequent issue of the Monitor national adaptations of the Guidelines were reported.

to previous section to next section
 

Last updated: May 3, 2013